#Caspase 8 Market Scope | Explore Tumblr posts and blogs

edwardebreen15 · 3 years ago

Text

Apoptosis Assay Market Global Industry Overview, Sales Revenue, Demand and Forecast by 2026

According to IMARC Group’s latest report, titled “Apoptosis Assay Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global apoptosis assay market exhibited strong growth during 2015-2020. Apoptosis assays are utilized by researchers to detect cellular and biochemical events associated with programmed cell death. They offer in-depth insights into small molecule and biological drugs, cell death mechanisms, functions of the immune system at the molecular level, etc. Currently, a significant rise in the incidences of cancer has increased the adoption of apoptosis assays to understand the effects of chemotherapy and gene drugs in both in vivo and in vitro conditions. Apoptosis assays determine the sensitivity of given cancer cells to a specific medicine and aid in developing a therapeutic strategy accordingly.

Request for a PDF sample of this report: https://www.imarcgroup.com/apoptosis-assay-market/requestsample

The extensive adoption of clinical cytotoxic and cytoprotective agents in treating cancer, ischemic diseases, neurodegenerative diseases, etc., is driving the apoptosis assay market. Furthermore, real-time and live-cell assays are gaining traction with numerous other methods to monitor apoptotic events over time. Moreover, the growing focus on extensive research and development on therapeutic drugs is also catalyzing the market growth. Additionally, various pharmaceutical manufacturers are launching innovative and economical assay kits, instruments, reagents, etc., which is contributing to the market growth. Besides this, several researchers have discovered that the coronavirus infection (COVID-19) triggers cell apoptosis and inflammatory cytokine processing in the lung cells and activates caspase-8. This, in turn, is expected to expand the applications of apoptosis assays in the coming years. Looking forward, IMARC Group expects the global apoptosis assay market to grow at a CAGR of around 8% during the next five years.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Competitive Landscape with Key Players:

Abcam plc

Agilent Technologies Inc.

Becton Dickinson and Company

Bio-Rad Laboratories Inc.

Bio-Techne Corporation

Merck KGaA

PerkinElmer Inc.

Promega Corporation

Sartorius Aktiengesellschaft

Takara Bio Inc.

Thermo Fisher Scientific Inc.

Market Segmentation:

Breakup by Product:

Kits

Reagents

Instruments

Others

Breakup by Technique:

Flow Cytometry

Fluorescence Microscopy

Spectrophotometry

Others

Breakup by Assay Type:

Caspase Assay

DNA Fragmentation Assay

Cell Permeability Assay

Mitochondrial Assay

Breakup by End Use:

Pharmaceutical and Biotechnology Companies

Hospital and Diagnostic Laboratories

Academic and Research Institutes

Breakup by Region:

North America (United States, Canada)

Europe (Germany, France, United Kingdom, Italy, Spain, Others)

Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)

Latin America (Brazil, Mexico, Others)

Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/apoptosis-assay-market

We are updating our reports, if you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Key highlights of the report:

Market Performance (2015-2020)

Market Outlook (2021-2026)

Market Trends

Market Drivers and Success Factors

The Impact of COVID-19 on the Global Market

Value Chain Analysis

Structure of the Global Market

Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization. Related Reports by IMARC Group:

Complementary and Alternative Medicine Market: https://www.imarcgroup.com/complementary-alternative-medicine-market

Catheters Market: https://www.imarcgroup.com/catheters-market

Trauma Care Centers Market: https://www.imarcgroup.com/trauma-care-centers-market

Laboratory Proficiency Testing Market: https://www.imarcgroup.com/laboratory-proficiency-testing-market

Extracorporeal Membrane Oxygenation Machine Market: https://www.imarcgroup.com/extracorporeal-membrane-oxygenation-machine-market

Medical Tapes and Bandages Market: https://www.imarcgroup.com/medical-tapes-bandages-market

Oligonucleotide Synthesis Market: https://www.imarcgroup.com/oligonucleotide-synthesis-market

Surgical Microscopes Market: https://www.imarcgroup.com/surgical-microscopes-market

Defibrillators Market: https://www.imarcgroup.com/defibrillators-market

Digital Health Market: https://www.imarcgroup.com/digital-health-market

Pharmacy Automation Market: https://www.imarcgroup.com/pharmacy-automation-market

Cell Analysis Market: https://www.imarcgroup.com/cell-analysis-market

Organic and Natural Pet Food Market: https://www.imarcgroup.com/organic-natural-pet-food-market

Angioplasty Balloons Market: https://www.imarcgroup.com/angioplasty-balloons-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, and nanotechnology industries. We also provide cost model and manufacturing setup project reports through Syndicated Analytics, a subsidiary of IMARC Group. Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations. Contact US: IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming

Email: [email protected]

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

#Apoptosis Assay Market

0 notes

tri-report · 4 years ago

Text

Caspase 8 Market Overview by New Technology, Demand and Scope 2020 to 2025

The Global Caspase 8 Market Research Report 2020-2025 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data that enhances the understanding, scope, and application of this report.

Top Companies in the Global Caspase 8 Market: BeyondSpring Pharmaceuticals Inc, Conatus Pharmaceuticals Inc, Novartis AG AndOther

Click the link to get a Sample Copy of the Report: (Special Offer: Available Flat 30% Discount for a limited time only):

https://www.theresearchinsights.com/ask_for_discount.php?id=380323

This report segments the Caspase 8Market on the basis of by Type are:

IDN-7314 MBRI-001 Others

On the basis of By Application, the Caspase 8Market is segmented into:

Liver Cirrhosis Metastatic Brain Tumor Others

Regional Analysis for Caspase 8 Market:

For a comprehensive understanding of market dynamics, the Caspase 8 Market is analyzed across key geographies namely: United States, China, Europe, Japan, South-east Asia, India, and others. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Explore Full Report With Detailed TOC Here:

https://www.theresearchinsights.com/life-and-medical/COVID-19-Global–China-Caspase-8-Market-Research-by-Company-Type–Application-2015-2026-380323

Points Covered in The Report:

The points that are talked over within the report are the major Caspase 8 Market players that influence the market such as raw material suppliers, manufacturers, equipment suppliers, end users, traders, distributors etc.

The all-inclusive profile of the companies is specified. The production, price, capacity, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, future strategies, supply, and the technological developments that they are creating are also incorporated within the report. Besides the historical data from 2014 to 2019 and forecast data from 2019 to 2025.

The growth factors of the Caspase 8 Market are deeply discussed while the different end users of the market are underlined.

Data and information by manufacturer, by region, by type, by application and etc., and custom research can be added in line with the specific requirements.

TheCaspase 8 Market report also considers the SWOT analysis of the market. Finally, the report concludes with the opinions of the industry experts.

What are the market factors that are explained in the report

Further in the Caspase 8 Market research reports, following points are included along with in-depth study of each point:-

Production Analysis – Production of the Caspase 8 Market is analyzed with respect to different regions, types and applications. Here, price analysis of various Caspase 8 Market key players are also covered.

Sales and Revenue Analysis – Both, sales and revenue are studied for the different regions of the Caspase 8 Market. Another major aspect, price, which plays important part in the revenue generation, is also assessed in this section for the various regions.

Supply and Consumption – In continuation with sales, this section studies supply and consumption for theCaspase 8Market. This part also sheds light on the gap between supple and consumption. Import and export figures are also given in this part.

Competitors – In this section, various Caspase 8 Market leading players are studied with respect to their company profile, product portfolio, capacity, price, cost and revenue.

Other analyses – Apart from the aforementioned information, trade and distribution analysis for the Caspase 8Market, contact information of major manufacturers, suppliers and key consumers is also given. Also, SWOT analysis for new projects and feasibility analysis for new investment are included.

Customization of the Report: This report can be customized as per your needs for additional data up to 3 companies or countries or 40 analyst hours.

Note: All the reports that we list have been tracking the impact of COVID-19 on the market. Both upstream and downstream of the entire supply chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

About Us:

The Research Insights – A global leader in analytics, research and advisory that can assist you to renovate your business and modify your approach. With us, you will learn to take decisions intrepidly. We make sense of drawbacks, opportunities, circumstances, estimations and information using our experienced skills and verified methodologies. Our research reports will give you an exceptional experience of innovative solutions and outcomes. We have effectively steered businesses all over the world with our market research reports and are outstandingly positioned to lead digital transformations. Thus, we craft greater value for clients by presenting advanced opportunities in the global market.

Robin

Sales manager

Contact number: +91-996-067-0000 || [email protected]

https://www.theresearchinsights.com

0 notes

amanjadejablog · 6 years ago

Text

Caspase 9 Market – How the Market Will Witness Substantial Growth in the Upcoming years

“The Caspase 9 market report is a complete research on the current state of the Caspase 9 market with a focus on the regional market. This report presents the global Caspase 9 market size (value, production, and consumption), splits the breakdown (data status 2013-2018 and forecast to ‘2025’), by manufacturers, region, type, and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis.

This research is helpful for all the players operating in the market, including the well-established players and the new entrants. This intelligent study provides the definition, description, and the overall forecasts of the global market, considering the market segments and sub-segments, which includes the product types, technologies, end-users, industry verticals, and the key geographies. Moreover, the report also provides an in-depth analysis of some of the significant factors such as driving forces, challenges, and threats that will shape the future of the market. In addition, the report also includes the lucrative opportunities in the micro markets for all the participants to invest in the global Caspase 9 market. Besides, the report describes the product offerings and the competitive analysis of the major players operating in the market.

Get a FREE Sample PDF Report: https://www.marketgrowthinsight.com/sample/15861

The report also presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market.

The key players covered in this report:

The major manufacturers covered in this report Bellicum Pharmaceuticals Inc BeyondSpring Pharmaceuticals Inc Conatus Pharmaceuticals Inc Pharmedartis GmbH

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering North America Europe China Japan Southeast Asia India

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Emricasan Flavokawain A MBRI-001 Plinabulin Other

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including Metabolic Disorder Hematological Disorder Gliblastoma Multiforme Pancreatic Cancer Others

This report studies the global Caspase 9 market status and forecast, categorizes the global Caspase 9 market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

Get Discount on this Report: https://www.marketgrowthinsight.com/discount/15861

The prime objective of this Caspase 9 research report is to define the size of the different segments and the geographies as well as to forecast the trends that are likely to gain traction in the following couple of years. This market research report has been designed to incorporate both the qualitative and quantitative aspects of the industry within each of the regions.

The scope of this report centers on key market analyses, market drivers & challenges, and competitive analysis & trends. Research report examines each market and its applications, regulatory scenario, technological innovations, Caspase 9 market projections, market sizes, and shares. Moreover, the Caspase 9 market report examines the most recent trends, pipeline products and developments in the Caspase 9 market. Complete profiles of leading organizations in the market are also mentioned in this report.

Caspase 9 market report highlights: 1. The Caspase 9 research report provides a detailed survey of the current and future industry trends so as to identify the investment analysis. 2. The industry forecasts, using estimated market values have been mentioned, till ‘2025’. 3. The Caspase 9 Market dynamics such as the drivers, restraints, threats, opportunities, and industry-specific challenges 4. Key industry trends across all the market segments and sub-segments, geographies, and nations. 5. Key developments and strategies determined in the market. 6. Detailed profiling of the leading competitors and the entrant market players. 7. Growth prospects among the emerging nations throughout the forecast period. 8. The Caspase 9 Market opportunities and recommendations for new investments.

In the end, It includes the methodical description of the various factors such as the market growth and a detailed information about the different company’s revenue, growth, technological developments, production, and the various other strategic developments.

Purchase Caspase 9 Market Research Report: https://www.marketgrowthinsight.com/checkout/15861

Thus, the Caspase 9 Market Report serves as a valuable material for all industry competitors and individuals having a keen interest in Caspase 9 Market study.

About us : Market Growth Insight, is a one stop solution for market research reports in various business categories. We are serving 100+ clients with 10000+ diverse industry reports and our reports are developed to simplify strategic decision making, on the basis of comprehensive and in-depth significant information, established through wide ranging analysis and latest industry trends. Contact us : 502, Sai Radhe, Kenedy Road, Behind Hotel Sheraton Grand, Near Pune Station, Pune-411001, [email protected] + 91 8956 049 020

Connect With Us : Twitter | Linkedin | Facebook | Google+

from WordPress http://bit.ly/2J03Gkt via IFTTT

#IFTTT #WordPress

0 notes

bunnyroy · 7 years ago

Text

Global Caspase 8 Market- Worldwide Analysis of Company Profile’s Forecast to 2018-2023

MarketResearchNest.com presents “Global Caspase 8 Sales Market Report 2018” new document to its studies database. The records spread across 100 with more than one tables and figures in it. Description:- Global Caspase 8 Market Report 2017 offered by MarketResearchNest contains a market overview of the industry which talks about market size, product scope, market revenue, growth opportunities,…

View On WordPress

#Caspase 8 #Caspase 8 Industry #Caspase 8 Industry Analysis.#Caspase 8 Market #Caspase 8 Market Analysis #Caspase 8 Market Growth #Caspase 8 Market Share

0 notes

marketforecastreport-blog · 7 years ago

Text

Granzyme B (C11 Or CTLA 1 Or Cathepsin G Like 1 Or Cytotoxic T Lymphocyte Proteinase 2 ) - Pipeline Review, H1 2017: Radiant Insights, Inc

Granzyme B (C11 or CTLA 1 or Cathepsin G Like 1 or Cytotoxic T Lymphocyte Proteinase 2 or Fragmentin 2 or Granzyme 2 or Human Lymphocyte Protein or SECT or T Cell Serine Protease 1-3E or GZMB or EC 3.4.21.79) pipeline Target constitutes close to 10 molecules. Out of which approximately 10 molecules are developed by Companies. The latest report Granzyme B - Pipeline Review, H1 2017, outlays comprehensive information on the Granzyme B (C11 or CTLA 1 or Cathepsin G Like 1 or Cytotoxic T Lymphocyte Proteinase 2 or Fragmentin 2 or Granzyme 2 or Human Lymphocyte Protein or SECT or T Cell Serine Protease 1-3E or GZMB or EC 3.4.21.79) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. Browse Full Research Report With TOC: http://www.radiantinsights.com/research/granzyme-b-c11-or-ctla-1-or-cathepsin-g-like-1 Granzyme B (C11 or CTLA 1 or Cathepsin G Like 1 or Cytotoxic T Lymphocyte Proteinase 2 or Fragmentin 2 or Granzyme 2 or Human Lymphocyte Protein or SECT or T Cell Serine Protease 1-3E or GZMB or EC 3.4.21.79) - Granzyme B is a serine protease secreted by granules of cytotoxic lymphocytes (CTLs), natural killer cells (NK cells) and cytotoxic T cells. Granzyme B is crucial for the rapid induction of target cell death by apoptosis, induced by interaction with cytotoxic T cells. It activates the intracellular cascade of caspases finally resulting in the killing of the target cells. The molecules developed by companies in Preclinical and Discovery stages are 8 and 2 respectively. Report covers products from therapy areas Dermatology, Immunology, Cardiovascular, Metabolic Disorders, Central Nervous System, Oncology and Toxicology which include indications Diabetic Foot Ulcers, Aortic Aneurysm, Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE), Hypertrophic Scars, Keloids, Skin Ulcers, Wounds, Abdominal Aortic Aneurysms, Alopecia, Dermal Ulcers, Multiple Myeloma (Kahler Disease), Multiple Sclerosis, Radiodermatitis, Rheumatoid Arthritis and Systemic Sclerosis (Scleroderma). Furthermore, this report also reviews key players involved in Granzyme B (C11 or CTLA 1 or Cathepsin G Like 1 or Cytotoxic T Lymphocyte Proteinase 2 or Fragmentin 2 or Granzyme 2 or Human Lymphocyte Protein or SECT or T Cell Serine Protease 1-3E or GZMB or EC 3.4.21.79) targeted therapeutics development with respective active and dormant or discontinued projects. Driven by data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data. Scope:

The report provides a snapshot of the global therapeutic landscape for Granzyme B (C11 or CTLA 1 or Cathepsin G Like 1 or Cytotoxic T Lymphocyte Proteinase 2 or Fragmentin 2 or Granzyme 2 or Human Lymphocyte Protein or SECT or T Cell Serine Protease 1-3E or GZMB or EC 3.4.21.79)

The report reviews Granzyme B (C11 or CTLA 1 or Cathepsin G Like 1 or Cytotoxic T Lymphocyte Proteinase 2 or Fragmentin 2 or Granzyme 2 or Human Lymphocyte Protein or SECT or T Cell Serine Protease 1-3E or GZMB or EC 3.4.21.79) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved in Granzyme B (C11 or CTLA 1 or Cathepsin G Like 1 or Cytotoxic T Lymphocyte Proteinase 2 or Fragmentin 2 or Granzyme 2 or Human Lymphocyte Protein or SECT or T Cell Serine Protease 1-3E or GZMB or EC 3.4.21.79) targeted therapeutics and enlists all their major and minor projects

The report assesses Granzyme B (C11 or CTLA 1 or Cathepsin G Like 1 or Cytotoxic T Lymphocyte Proteinase 2 or Fragmentin 2 or Granzyme 2 or Human Lymphocyte Protein or SECT or T Cell Serine Protease 1-3E or GZMB or EC 3.4.21.79) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news and deals related to Granzyme B (C11 or CTLA 1 or Cathepsin G Like 1 or Cytotoxic T Lymphocyte Proteinase 2 or Fragmentin 2 or Granzyme 2 or Human Lymphocyte Protein or SECT or T Cell Serine Protease 1-3E or GZMB or EC 3.4.21.79) targeted therapeutics

See More Reports of This Category by Radiant Insights: http://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare Reasons To Buy:

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand the targeted therapy areas and indications for Granzyme B (C11 or CTLA 1 or Cathepsin G Like 1 or Cytotoxic T Lymphocyte Proteinase 2 or Fragmentin 2 or Granzyme 2 or Human Lymphocyte Protein or SECT or T Cell Serine Protease 1-3E or GZMB or EC 3.4.21.79)

Identify the use of drugs for target identification and drug repurposing

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Granzyme B (C11 or CTLA 1 or Cathepsin G Like 1 or Cytotoxic T Lymphocyte Proteinase 2 or Fragmentin 2 or Granzyme 2 or Human Lymphocyte Protein or SECT or T Cell Serine Protease 1-3E or GZMB or EC 3.4.21.79) development landscape

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

About Radiant Insights,Inc Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions. Contact Details: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc 28 2nd Street, Suite 3036, San Francisco, CA 94105, United States Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: [email protected] Web: http://www.radiantinsights.com/

#Pharmaceuticals-and-healthcare Granzyme B (C11 Or CTLA 1 Or Cathepsin G Like 1 Or Cytotoxic T Lymphocyte Proteinase 2 ) Granzyme B Granzyme

0 notes

soumyafwr · 11 months ago

Text

https://twikkers.nl/blogs/174365/Caspase-8-Market-Overview-Competitive-Analysis-and-Forecast-2031

Caspase 8 Market Overview, Competitive Analysis and Forecast 2031

#Caspase 8 Market #Caspase 8 Market Scope #Caspase 8 Market Report #Caspase 8 Market Research

0 notes

helloancycruzworld · 7 years ago

Text

Serine/ Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2. 7. 11. 1) Pipeline Review H1 2017 Research Report Now Available at Orbis Research

Description:

Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) pipeline Target constitutes close to 8 molecules. Out of which approximately 7 molecules are developed by companies and remaining by the universities/institutes. The latest report SerineThreonine Protein Kinase Pim 1 - Pipeline Review, H1 2017, outlays comprehensive information on the Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/310023 .

Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - Proto-oncogene serine/threonine-protein kinase Pim-1 is an enzyme encoded by the PIM1 gene. It promotes cell cycle progression and tumorigenesis by down-regulating expression of a regulator of cell cycle progression CDKN1B at both transcriptional and post-translational levels. It mediates survival signaling through phosphorylation of BAD which induces release of the anti-apoptotic protein Bcl-X (L)/BCL2L1. It phosphorylation of MAP3K5, another proapoptotic protein by PIM1 significantly decreases MAP3K5 kinase activity and inhibits MAP3K5-mediated phosphorylation of JNK and JNK/p38MAPK subsequently reducing caspase-3 activation and cell apoptosis. The molecules developed by companies in Phase II and Preclinical stages are 2 and 5 respectively. Similarly, the universities portfolio in Discovery stages comprises 1 molecules, respectively. Report covers products from therapy areas Oncology and Immunology which include indications Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), Prostate Cancer, Chronic Lymphocytic Leukemia (CLL), Bladder Cancer, Hematological Tumor, Lymphoma, Myelodysplastic Syndrome, Myelofibrosis, Non-Small Cell Lung Carcinoma, Pancreatic Cancer, Psoriasis, Refractory Acute Myeloid Leukemia, Refractory Multiple Myeloma, Relapsed Acute Myeloid Leukemia, Relapsed Multiple Myeloma and Transitional Cell Carcinoma (Urothelial Cell Carcinoma).

Furthermore, this report also reviews key players involved in Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) targeted therapeutics development with respective active and dormant or discontinued projects. Driven by data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Browse the full report @ http://www.orbisresearch.com/reports/index/serine-threonine-protein-kinase-pim-1-oncogene-pim1-or-pim1-or-ec-2-7-11-1-pipeline-review-h1-2017 .

Scope - The report provides a snapshot of the global therapeutic landscape for Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - The report reviews Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1)targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1)targeted therapeutics and enlists all their major and minor projects - The report assesses Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type - The report summarizes all the dormant and discontinued pipeline projects - The report reviews latest news and deals related to Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) targeted therapeutics

Reasons to buy - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand the targeted therapy areas and indications for Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - Identify the use of drugs for target identification and drug repurposing - Identify potential new clients or partners in the target demographic - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1)development landscape - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Purchase a copy of this report @ http://www.orbisresearch.com/contact/purchase/310023 .

Companies Mentioned Incyte Corp Inflection Biosciences Ltd Jasco Pharmaceuticals LLC Novartis AG Tolero Pharmaceuticals Inc

For any enquires before buying, connect with us @ [email protected]

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas - 75204, U.S.A.

Phone No.: +1 (214) 884-6817; +912064101019

For more information contact [email protected]

#medical

0 notes

edwardebreen15 · 3 years ago

Text

Apoptosis Assay Market Share, Trends, Growth, Sales, Demand, Revenue, Size, Forecast and COVID-19 Impacts to 2021-2026